Company Filing History:
Years Active: 1993
Title: Innovations of Srinivasan Varadarajan in Anti-Parasitic Compounds
Introduction
Srinivasan Varadarajan is an accomplished inventor based in Stow, Ohio, known for his significant contributions to the field of anti-parasitic compounds. With a focus on developing novel compounds that exhibit high levels of anti-parasitic activity, he has made strides in addressing diseases caused by parasites of the genus Trypanosoma. His work is particularly relevant in the context of public health and veterinary medicine.
Latest Patents
Varadarajan holds a patent for "Compounds exhibiting anti-parasitic activity and a method for their use." This patent describes innovative compounds that are effective against Trypanosoma parasites. The compounds consist of aryl-substituted quaternary heteroaromatic salts, which include a positively charged imidazolium or other heterocyclic ring, a linking group, a phenyl ring, and a polar functional group. The polar functional group is preferably a quanylhydrazone or a heterocyclic hydrazone. The patent also outlines a method for treating diseases associated with Trypanosoma parasites by administering an effective amount of these compounds to infected animals or humans.
Career Highlights
Srinivasan Varadarajan is currently associated with the US Government as represented by the Secretary of the Army. His role involves research and development in the field of anti-parasitic treatments, contributing to advancements in medical and veterinary applications. His work has the potential to impact the treatment of diseases that affect both humans and animals.
Collaborations
Varadarajan has collaborated with notable colleagues, including Richard J Sundberg and Daniel J Dahlhausen. These collaborations have likely enhanced the research and development process, leading to innovative solutions in combating parasitic infections.
Conclusion
Srinivasan Varadarajan's contributions to the field of anti-parasitic compounds highlight the importance of innovation in addressing health challenges. His patented work represents a significant advancement in the fight against Trypanosoma parasites, showcasing the potential for new treatments that can benefit both humans and animals.